Abstract
The increase of pharmaceutical drugs formulations consumption by Brazilian population demanded a greater action from the official laboratory to verify the conformity of these products, as the majority of them are composed by anxiolytics. This study reports a serious manipulation error in preparing alprazolam capsules formulation, where the chlordiazepoxide was placed instead of alprazolam, being both drugs belonged to therapeutic class of the benzodiazepines. A warning on the importance of manipulation process control of drugs is presented.References
1. Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. JClin Psychiatry 2004; 65 Suppl 5: 7-12.
2. Goodman & Gilman. As Bases Farmacológicas da Terapêutica, 11a ed., Rio de Janeiro: McGraw-Hill Interamericana do Brasil; 2005, 1847 p.
3. Sweetman SC. The Martindale the complete drugreference, 34th ed., London: The Pharmaceutical Press; 2005, 3187 p.
4. Farmacopéia Brasileira, 4a ed. São Paulo: Ed. Atheneu, 1988.
5. The United States Pharmacopeia, 28th ed. Rockville: United States Pharmacopeial Convention Inc.; 2005, 3187 p.
6. Moffat AC, editor. Clarke’s isolation and identification of drugs, 2nd ed., London: The Pharmaceutical Press;1986, 1223 p.
7. Chaves MA, Akatuka AS, Trujillo LM. Dietilpropiona, femproporex, diazepam e fenolftaleína: determinação em formulações para emagrecimento. Rev Inst Adolfo Lutz 1994; 54(1): 36-43.
8. Auricchio MT, Batistic MA, Markman BEO. Detecção de anorexígenos e benzodiazepínicos em formulações “naturais” empregadas em regimes de emagrecimento. Rev Inst Adolfo Lutz 1991; 51 (1/2): 105-10.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2007 Instituto Adolfo Lutz Journal